Answers are grounded in this paper and cite their sources.
Review (non-alcoholic fatty liver disease, NAFLD) , (triglyceride) 5% (metabolic disease) (simple steatosis), (inflammation) (steatohepatitis), (apoptosis) (cirrhosis) , . 1 (diabetes), (hypertension), (cardiovascular disease) . 2 (obesity)
No takes yet. Share an insight, caveat, or question.
Cho et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: